Guideline Recommendations for HER2 Testing in Breast Cancer: Summary Slide Set

QualityTool

Guideline Recommendations for HER2 Testing in Breast Cancer: Summary Slide Set

Description

This slideshow presentation summarizes the American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 (HER2) Testing in Breast Cancer.

This slideshow contains 25 slides and is organized into the following sections:

  • Introduction
  • Guideline methodology
  • Background
  • Guideline questions
  • Optimal testing algorithm for the assessment of HER2 status
  • Optimal performance, interpretation, and reporting
  • Additional ASCO/CAP resources

Developer:

American Society of Clinical Oncology; College of American Pathologists

Funding Sources:

American Society of Clinical Oncology; College of American Pathologists

History

Release Date: 2006
Original Summary: June 2007
Last Updated: 04/10/13

Disclaimer: The inclusion of a tool in the Innovations Exchange does not constitute or imply an endorsement by the U.S. Department of Health and Human Services, the Agency for Healthcare Research and Quality or Westat of the tool or of the submitter or developer of the tool. Read more.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.